Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 282 participants.

Also called NCT06744361

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 282 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06744361
  • EU CT 2024-515987-29-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06744361. Randomized; quadruple masking; primary purpose treatment. Start 2024-12-12 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
Acronym
KETOHCA
Condition
Out-of-hospital Cardiac Arrest (OHCA)
Intervention (Drug)
esketamine hydrochloride
Intervention (Drug)
propofol
Lead sponsor
Christian Hassager (class: other)

Record details

Record id
cardio:ct-nct06744361
Content hash
0a6fc26334715c5bb0132e7ba31a466a97c237d84c19232c81ea9a3fc196aaff